Ullevål PersonalityProject - Trial NCT00378248
Access comprehensive clinical trial information for NCT00378248 through Pure Global AI's free database. This phase not specified trial is sponsored by Oslo University Hospital and is currently status unknown. The study focuses on Personality Disorders. Target enrollment is 120 participants.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.
Study Focus
Sponsor & Location
Oslo University Hospital
Timeline & Enrollment
N/A
May 01, 2004
Dec 01, 2016
Primary Outcome
Psychosocial functioning,symptom distress,self esteem,interpersonal problems,,self destructive behavior,,personality pathology,,quality of life,,health care utilization after
Summary
Ullevål PersonalityProject is a ranomized controlled trial of treatment of patients with
 personality disorder. It's main purpose is to test the effect of a long-term combined
 treatment program compared with eclectic individual therapy for patients with personality
 disorders.
 
 The main study hypothesis is that long-term combined treatment is superior to eclectic
 individual therapy with respect to improvement in personality functioning, psychosocial
 functioning, symptoms, interpersonal problems, and self destructive behavior for poorly
 functioning patients with personality disorders.
ICD-10 Classifications
Data Source
ClinicalTrials.gov
NCT00378248
Non-Device Trial

